HR 1796
18 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Congress · In committee
Every link on this map
The same connections as a table, with the reason each one is here.
| Audre Zembrzuski | Gave to its sponsors | Audre Zembrzuski gave $40K to a sponsor of HR 1796. A gift is not a position on the bill. | $40K |
| Janet James | Gave to its sponsors | Janet James gave $37K to a sponsor of HR 1796. A gift is not a position on the bill. | $37K |
| Gregg Williams | Gave to its sponsors | Gregg Williams gave $28K to a sponsor of HR 1796. A gift is not a position on the bill. | $28K |
| Jeffrey Olyan | Gave to its sponsors | Jeffrey Olyan gave $27K to a sponsor of HR 1796. A gift is not a position on the bill. | $27K |
| Charles W Harding | Gave to its sponsors | Charles W Harding gave $20K to a sponsor of HR 1796. A gift is not a position on the bill. | $20K |
| Jerry Wagner | Gave to its sponsors | Jerry Wagner gave $20K to a sponsor of HR 1796. A gift is not a position on the bill. | $20K |
| Alecia Kruger | Gave to its sponsors | Alecia Kruger gave $20K to a sponsor of HR 1796. A gift is not a position on the bill. | $20K |
| Stephen R. Zynda | Gave to its sponsors | Stephen R. Zynda gave $18K to a sponsor of HR 1796. A gift is not a position on the bill. | $18K |
| John James | Sponsors | John James sponsored HR 1796. | None |
| Terumo BCT, Inc. | Lobbied on it | Terumo BCT, Inc. named HR 1796 in 10 lobbying reports. | 10 reports |
| Artemis Policy Group LLC | Lobbied on it | Artemis Policy Group LLC named HR 1796 in 6 lobbying reports. | 6 reports |
| Fulcrum Therapeutics | Lobbied on it | Fulcrum Therapeutics named HR 1796 in 5 lobbying reports. | 5 reports |
| Sickle Cell Disease Association of America | Lobbied on it | Sickle Cell Disease Association of America named HR 1796 in 5 lobbying reports. | 5 reports |
| The McManus Group | Lobbied on it | The McManus Group named HR 1796 in 5 lobbying reports. | 5 reports |
| Leavitt Partners, LLC on Behalf of Sickle Cell Disease Partnership | Lobbied on it | Leavitt Partners, LLC on Behalf of Sickle Cell Disease Partnership named HR 1796 in 4 lobbying reports. | 4 reports |
| OGR | Lobbied on it | OGR named HR 1796 in 4 lobbying reports. | 4 reports |
| Indigo Hill Strategies | Lobbied on it | Indigo Hill Strategies named HR 1796 in 3 lobbying reports. | 3 reports |
| Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 | Source records | HR 1796 has an explicit source reference to Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…